Ledger.Open graph →
SEC Form D · filed December 11, 2018

Quellis Biosciences, Inc

Offering
$18.5M
Sold
$2.5M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
PHILADELPHIA, PA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (10)

Tomas Kiselak · Philadelphia, PAExec · DirectorPeter Harwin · Philadelphia, PAExec · DirectorChristopher Garabedian · Philadelphia, PADirectorDavid H. Treitel · Boca Raton, FLExec · DirectorStephen M. Wagman · Boca Raton, FLExec · DirectorFrederick Callori · Philadelphia, PADirectorDebora M. Covell · Wyomissing, KYExec · DirectorJames C. Waldinger · New York, NYExec · DirectorChristopher Garabedian · Philadelphia, PADirectorFrederick Callori · Philadelphia, PADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗